
Please try another search
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases. Its lead candidate is VTP-1000, which is in Phase 1 clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease. The company is also developing VTP-300, an immunotherapeutic targeting chronic hepatitis B virus infection; VTP-200, a potential non-invasive treatment for persistent high-risk human papillomavirus; VTP-850, an immunotherapeutic candidate for prostate cancer; VTP-600, an immunotherapeutic candidate targeting MAGE-A3 and NY-ESO1 antigens; VTP-500, a prophylactic vaccine candidate to prevent middle east respiratory syndrome; VTP-400, a prophylactic vaccine candidate for shingles; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Didcot, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Robin Wright | 60 | 2018 | Independent Chairman of the Board |
Pierre Armand Morgon | 61 | 2018 | Independent Non-Executive Director |
Alex Hammacher | 44 | 2020 | Non-Executive Director |
Anne M. Phillips | 70 | 2021 | Independent Non-Executive Director |
Karen A. Dawes | 73 | 2021 | Independent Non-Executive Director |
Benoit Van den Eynde | - | - | Member of Scientific Advisory Board |
Mark Tuthill | - | - | Member of Scientific Advisory Board |
Joseph C. F. Scheeren | 68 | 2021 | Independent Non-Executive Director |
William J. Enright | 63 | 2019 | CEO, Director & Principal Financial Officer |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review